Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06335160Recruiting
- Sponsor
- Tanta University
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of mebendazole in ulcerative colitis (UC) (2 arms), sponsored by Tanta University. Primary endpoints: Change in disease activity at 6 months and Partial Mayo Scoring Index at 6 months. Started Apr 2024; status: recruiting.
02
Drugs
mebendazole
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06335160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06335160.